Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Cholangiocarcinoma risk factors
Introduction
Overview
Overview
Common risk factors in the development of cholangiocarcinoma include primary sclerosing cholangitis, fibropolycystic liver disease such as choledochal cysts, hepatolithiasis and recurrent pyogenic cholangitis.
Risk Factors
Risk Factors
- Common risk factors in the development of cholangiocarcinoma include primary sclerosing cholangitis, fibropolycystic liver disease such as choledochal cysts, hepatolithiasis and recurrent pyogenic cholangitis.
Common Risk Factors
- Common risk factors in the development of cholangiocarcinoma include:[1][2][3][4][5]
- Primary sclerosing cholangitis
- Cirrhosis
- Viral infections
- Liver fluke infections
- Hepatolithiasis
- Choledochal cysts
- Infusion of certain chemical agents such as naphthenic acids
- Recurrent pyogenic cholangitis
- Opisthorchis viverrini
- Clonorchis sinensis
- Caroli’s disease
- Inherited disorders
- Lynch syndrome
- Biliary papillomatosis
Less Common Risk Factors
References
References
- ↑ Al-Bahrani R, Abuetabh Y, Zeitouni N, Sergi C (2013). “Cholangiocarcinoma: risk factors, environmental influences and oncogenesis”. Ann. Clin. Lab. Sci. 43 (2): 195–210. PMID 23694797.
- ↑ Tyson GL, El-Serag HB (2011). “Risk factors for cholangiocarcinoma”. Hepatology. 54 (1): 173–84. doi:10.1002/hep.24351. PMC 3125451. PMID 21488076.
- ↑ Ben-Menachem T (2007). “Risk factors for cholangiocarcinoma”. Eur J Gastroenterol Hepatol. 19 (8): 615–7. doi:10.1097/MEG.0b013e328224b935. PMID 17625428.
- ↑ Gatto M, Alvaro D (2010). “Cholangiocarcinoma: risk factors and clinical presentation”. Eur Rev Med Pharmacol Sci. 14 (4): 363–7. PMID 20496549.
- ↑ Acalovschi M (2004). “Cholangiocarcinoma: risk factors, diagnosis and management”. Rom J Intern Med. 42 (1): 41–58. PMID 15529594.
- ↑ Razumilava N, Gores GJ (2013). “Classification, diagnosis, and management of cholangiocarcinoma”. Clin. Gastroenterol. Hepatol. 11 (1): 13–21.e1, quiz e3–4. doi:10.1016/j.cgh.2012.09.009. PMC 3596004. PMID 22982100.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2], Suveenkrishna Pothuru, M.B,B.S. [3]